Primescan, the high-performance intraoral scanner from Dentsply Sirona, is an excellent starting point for digital workflows that can assist in further improving dental treatment in restorative dentistry, orthodontics, and implantology. Primescan is now validated for full arch fixed implant restorations with Atlantis suprastructures, mainly due to the proven accuracy1 of Primescan. It is now possible for the first time worldwide to use the Atlantis suprastructures service with scan data from Primescan.
Dentsply Sirona has validated a new workflow for clinically-efficient and digitally-supported implant treatment that includes all components, from impression to prosthetics. An essential part of this workflow is taking the digital impression with Primescan, which is characterized by ease of use, speed and very high accuracy[1] over the entire arch. All treatment steps are coordinated with each other and come together in an efficient implant dentistry workflow.
With the upgrade of Connect SW 5.2, dental professionals now have convenient access to high-quality, patient-specific Atlantis suprastructures, designed and manufactured using highly accurate digital impression taken by Primescan. New firmware makes the intraoral scanner twice as fast, provides a higher-performing scanning experience and gives users access to new workflows and even better usability*.
In the validated workflow with Atlantis, dentists benefit from a very high flexibility, as the individual steps can be carried out completely digitally and in collaboration with the laboratory. Dentsply Sirona offers the possibility of ordering prosthetic components, including a complete suprastructure for the partial or full-arch case, from the global Atlantis design and manufacturing sites, the company’s own digital laboratory.
Dentsply Sirona is the first to enable intraoral scans with Atlantis suprastructures for fixed multiple-unit implant restorations. Thanks to the proven accuracy1 of Primescan, it is the first and only intraoral scanner validated for the fully digital workflow for Atlantis suprastructures, which was previously only validated for laboratory scanners.
With Primescan, a digital impression can be taken for single teeth, quadrants, whole dentition and now also edentulous jaws with multiple implants placed based on the Atlantis IO FLO-S scanbody. Users can then transfer scan data to their preferred lab via the Connect Case Center. Based on the open data format, labs must be able to detect the IO FLO-S scanbody in their lab software and can start working on the case coming from Primescan, creating more efficiency between practice and lab. Once complete, the technician can upload all required data to Atlantis.
Simplified and improved workflow with Primescan*
The combination of Atlantis suprastructures and the full arch accuracy of Primescan assists in delivering an easier workflow for the dentist and the dental laboratory. Following this protocol, the clinician takes a digital impression using Primescan and Atlantis IO FLO-S Scanbodies. The partnering dental laboratory finalizes the order and sends it to Dentsply Sirona for design and manufacturing of the Atlantis suprastructure. The restoration is finalized by the lab technician and sent back to the clinician.
Atlantis patient-specific solutions
When function and esthetics are prioritized, a customized, patient-specific restoration probably is a natural choice. Atlantis patient-specific solutions are produced using state-of-the-art technologies and supported by computer based industrial and medical device expertise for a very high accuracy.
Moreover, additive manufacturing provides new possibilities for advanced geometries for fixed, screw-retained solutions in titanium or cobalt-chrome for all major implant systems. Atlantis includes a full range of dental implant suprastructures for fixed and removable splinted implant restorations.
“It is a big step forward to restore edentulous jaws using a digital workflow. This makes the process of planning, surgery and restoration between the clinician and the laboratory more coherent and offers very good esthetic results, while taking less clinical time,” explained Dr. Martin Wanendeya, dentist from London (UK). “Atlantis’ validation for Primescan gives us as practitioners the reassurance that it works reliably and consistently.”
This reliability was a major focus of the validation: Supporting implant restorations comprehensively with digital technology gives everyone involved peace of mind, ensuring that the planned treatment can be implemented predictably.
More information about Primescan can be found at www.dentsplysirona.com/primescan
* Unless stated otherwise, all comparative statements in this press release refer to a comparison between Dentsply Sirona products.
Due to the different approval and registration times, not all technologies and products are immediately available in all countries.
[1] https://assets.dentsplysirona.com/flagship/en/explore/digital-impression/documents/DIM-Document-Primescan-clinical-studies-overview-EN.pdf [Date of last access: 2021, July 5th]
ABOUT DENTSPLY SIRONA
Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solution offering, including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona’s headquarters are located in Charlotte, North Carolina. The company’s shares are listed in the United States on NASDAQ under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.
DISCLAIMER
This information and any attachment thereto contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance. These forward-looking statements reflect views and assumptions regarding expectations and projections about future events and are based on currently available information or information available on the date of any document incorporated by reference. You can generally identify these forward-looking statements by the use of words such as “may,” “could,” “estimate,” “will,” “believe,” “anticipate,” “think,” “intend,” “expect,” “project,” “plan,” “target,” “forecast”, and similar words and expressions. However, these words are not the exclusive means of identifying such statements. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements and may include statements relating to future revenues, expenses, margins, profitability, net income/(loss), earnings per share and other measures of results of operations and the prospects of future growth of our business. These forward-looking statements are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict. For a discussion of such risks, uncertainties and other matters that could cause actual results to differ materially, including risks relating to, among other factors, the market for dental products and services, pricing, future sales volume of the Company’s products, the possibility of changing economic, market and competitive conditions, dependence on products, dependence on key personnel, technological developments, intense competition, market uncertainties, dependence on distributors, ability to manage growth, dependence on key suppliers, dependence on key members of management, government regulation, our ability to integrate the businesses of Dentsply Sirona, acquisitions and affiliations, readers are urged to carefully review and consider various disclosures made by the Company and Dentsply Sirona in their public filings, including in their Annual Reports on Form 10-K and in their reports on Forms 10-Q and 8-K filed with the Securities and Exchange Commission.
Readers are cautioned not to place undue reliance on such statements, which speak only as of the date hereof. Except as required by law, the Company does not assume any obligation to update any forward-looking statements contained in this document or the attachments to reflect new information or future events or developments after the date any such statement is made.
[1] https://assets.dentsplysirona.com/flagship/en/explore/digital-impression/documents/DIM-Document-Primescan-clinical-studies-overview-EN.pdf [Date of last access: 2021, July 5th]
